60

Cowealth Medical China Co LtdSHG 603122 Stock Report

Last reporting period 30 Sep, 2023

Updated 18 Oct, 2024

Last price

Market cap $B

0.342

Micro

Exchange

XSHG - Shanghai Stock Exchange

603122.SS Stock Analysis

60

Uncovered

Cowealth Medical China Co Ltd is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

45/100

Low score

Market cap $B

0.342

Dividend yield

1.14 %

Shares outstanding

398.05 B

Cowealth Medical China Co Ltd is a CN-based company operating in Health Care Providers & Services industry. The company is headquartered in Shanghai, Shanghai and currently employs 229 full-time employees. The company went IPO on 2022-02-16. Cowealth Medical China Co Ltd is a China-based company mainly engaged in the wholesale of medical equipment products. The firm's businesses include in-vitro diagnostic product intensive business and medical product distribution business. The in-vitro diagnostic product intensive business is engaged in the wholesale business of in vitro diagnostic products, mainly including immunodiagnosis, biochemical diagnosis, clinical testing, real-time testing, molecular diagnosis, pathology, microbiological testing, blood source safety monitoring and others. The medical product distribution business mainly includes the wholesale sales of equipment in the field of swelling, immunodiagnosis and biochemical diagnosis. The firm mainly operates its business in the domestic market.

View Section: Eyestock Rating